SEC 13F Intelligence

Birchview Capital, LP / UTHR

Birchview Capital, LP’s United Therapeutics Corp Del Position

Does Birchview Capital, LP own United Therapeutics Corp Del (UTHR)? Yes — 4.5K shares worth $3M (+1.52% of its 13F portfolio) as of Q1 2026, up from 3.0K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
4.5K
% of Portfolio
+1.52%
Quarters Held
26
currently held

Position History UTHR

Reported value by quarter
Q4 ’19: $440,000Q4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $3MQ4 ’21: $4MQ4 ’21Q1 ’22: $3MQ2 ’22: $4MQ3 ’22: $3MQ4 ’22: $4MQ4 ’22Q1 ’23: $3MQ2 ’23: $3MQ3 ’23: $2MQ4 ’23: $2MQ4 ’23Q1 ’24: $3MQ2 ’24: $3MQ3 ’24: $4MQ4 ’24: $4MQ4 ’24Q1 ’25: $2MQ2 ’25: $1MQ3 ’25: $1MQ4 ’25: $1MQ4 ’25Q1 ’26: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.5K$3M+1.52%
Q4 20253.0K$1M+0.86%
Q3 20253.0K$1M+0.95%
Q2 20254.3K$1M+1.21%
Q1 20257.5K$2M+2.01%
Q4 202410.0K$4M+2.88%
Q3 202410.0K$4M+3.11%
Q2 202410.0K$3M+2.95%
Q1 202411.0K$3M+2.06%
Q4 202311.0K$2M+1.90%
Q3 202311.0K$2M+2.11%
Q2 202315.0K$3M+2.48%
Q1 202315.0K$3M+2.63%
Q4 202215.0K$4M+2.95%
Q3 202215.0K$3M+2.21%
Q2 202215.0K$4M+2.57%
Q1 202218.0K$3M+2.32%
Q4 202118.0K$4M+2.51%
Q3 202118.0K$3M+2.26%
Q2 202118.0K$3M+1.93%
Q1 202118.0K$3M+1.79%
Q4 202018.0K$3M+1.57%
Q3 202018.0K$2M+1.21%
Q2 202018.0K$2M+1.32%
Q1 202018.0K$2M+1.51%
Q4 20195.0K$440,000+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of UTHR.